Regencell Bioscience(RGC)
$4.72-0.22 (-4.45%)
RGC
Regencell Bioscience financials statements
$4.72
At close:-0.22 (-4.45%)
Regencell Bioscience (RGC) Income Statement
628 Followers
Regencell Bioscience Income Statement
Last quarter (Q4 2026), Regencell Bioscience's total revenue was $0.00. In Q4, Regencell Bioscience's net income was $-6.38M. See Regencell Bioscience’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -404.54K | $ -392.74K | $ -745.59K | $ -769.69K | $ -604.40K | |
| $ 11.32M | $ 3.38M | $ 3.99M | $ 6.27M | $ 7.62M | |
| Depreciation and Amortization | $ 404.54K | $ 392.74K | $ 745.59K | $ 769.69K | $ 604.40K |
| $ -11.32M | $ -3.19M | $ -3.62M | $ -5.29M | $ -6.99M | |
| $ -11.72M | $ -3.77M | $ -4.74M | $ -6.27M | $ -7.62M | |
| $ 22.52K | $ 185.77K | $ 373.50K | $ 211.34K | $ 23.21K | |
| $ -11.70M | $ -3.58M | $ -4.36M | $ -6.06M | $ -7.59M | |
| $ -11.70M | $ -3.58M | $ -4.30M | $ -5.87M | $ -7.42M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.02 | $ -0.01 | $ -0.01 | $ -0.01 | $ -0.02 |
| Diluted EPS | $ -0.02 | $ -0.01 | $ -0.01 | $ -0.01 | $ -0.02 |
| Weighted Average Shares Outstanding | 494.60M | 494.49M | 494.49M | 494.49M | 494.49M |
| Weighted Average Shares Outstanding (Diluted) | 494.60M | 494.49M | 494.49M | 494.49M | 494.49M |
Currency in USD

